miR-129-5p attenuates cell proliferation and epithelial mesenchymal transition via HMGB1 in gastric cancer
The miR-129-5p has been reported to be aberrant expression and exert vital roles in tumor progression of various malignancies. However, the effects on EMT in gastric cancer and its precise molecular mechanism in gastric cancer remain unclear. RT-qPCR was performed to evaluate the expression level of...
Gespeichert in:
| Veröffentlicht in: | Pathology, research and practice research and practice, 2019-04, Vol.215 (4), p.676-682 |
|---|---|
| Hauptverfasser: | , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 682 |
|---|---|
| container_issue | 4 |
| container_start_page | 676 |
| container_title | Pathology, research and practice |
| container_volume | 215 |
| creator | Wang, Shaocheng Chen, Yanyan Yu, Xiongfei Lu, Yimin Wang, Haoao Wu, Fusheng Teng, Lisong |
| description | The miR-129-5p has been reported to be aberrant expression and exert vital roles in tumor progression of various malignancies. However, the effects on EMT in gastric cancer and its precise molecular mechanism in gastric cancer remain unclear.
RT-qPCR was performed to evaluate the expression level of miR-129-5p and HMGB1 in cell lines. Cell proliferation was detected via CCK-8. The epithelial mesenchymal transition (EMT) related proteins and the expression of HMGB1 were detected by western blot analysis. Luciferase assays were used to validate binding seeds between miR-129-5p and HMGB1.
miR-129-5p was downregulated in gastric cancer cells compared with GES-1. At the same time EMT was promoted in gastric cancer cells compared to GES-1. Overexpression of miR-129-5p inhibited EMT and proliferation. MiR-129-5p negatively and directly targeted HMGB1. HMGB1 was upregulated in gastric cancer cells and HMGB1 knocked-down inhibited EMT and cell proliferation.
Taken together, upregulation of miR-129-5p associated with gastric cancer proliferation and EMT, and serves as a potential diagnostic and therapeutic target via miR-129-5p/HMGB1 pathway in gastric cancer. |
| doi_str_mv | 10.1016/j.prp.2018.12.024 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2179364458</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S034403381831598X</els_id><sourcerecordid>2179364458</sourcerecordid><originalsourceid>FETCH-LOGICAL-c353t-8c70e90f33e001501ce0aee13b6b307f28b7628183a4aebbbd8152477fc55b743</originalsourceid><addsrcrecordid>eNp9kE1P3DAQhq2qqCy0P6CXysdeEmZsJ_GKE6AWkEBIiJ4tx5kUr_KF7UXi3-NloceePLKeeTXvw9h3hBIB65NNuYSlFIC6RFGCUJ_YCmvUBdQSP7MVSKUKkFIfsqMYNwDQgMIv7FBmoBLYrNhm9PcFinVRLdymRNPWJorc0TDwJcyD7ynY5OeJ26njtPj0SIO3Ax8p0uQeX8Y8p2Cn6N-oZ2_51e3lOXI_8b82puAdd3ZyFL6yg94Okb69v8fsz-9fDxdXxc3d5fXF2U3hZCVToV0DtIZeSgLACtARWCKUbd1KaHqh26YWGrW0ylLbtp3GSqim6V1VtY2Sx-znPjff_7SlmMzo466QnWjeRpN7r2WtVKUzinvUhTnGQL1Zgh9teDEIZqfYbPLPYnaKDQqTFeedH-_x23ak7t_Gh9MMnO4ByiWfPQUTnc-uqPOBXDLd7P8T_woy-ov2</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2179364458</pqid></control><display><type>article</type><title>miR-129-5p attenuates cell proliferation and epithelial mesenchymal transition via HMGB1 in gastric cancer</title><source>Access via ScienceDirect (Elsevier)</source><creator>Wang, Shaocheng ; Chen, Yanyan ; Yu, Xiongfei ; Lu, Yimin ; Wang, Haoao ; Wu, Fusheng ; Teng, Lisong</creator><creatorcontrib>Wang, Shaocheng ; Chen, Yanyan ; Yu, Xiongfei ; Lu, Yimin ; Wang, Haoao ; Wu, Fusheng ; Teng, Lisong</creatorcontrib><description>The miR-129-5p has been reported to be aberrant expression and exert vital roles in tumor progression of various malignancies. However, the effects on EMT in gastric cancer and its precise molecular mechanism in gastric cancer remain unclear.
RT-qPCR was performed to evaluate the expression level of miR-129-5p and HMGB1 in cell lines. Cell proliferation was detected via CCK-8. The epithelial mesenchymal transition (EMT) related proteins and the expression of HMGB1 were detected by western blot analysis. Luciferase assays were used to validate binding seeds between miR-129-5p and HMGB1.
miR-129-5p was downregulated in gastric cancer cells compared with GES-1. At the same time EMT was promoted in gastric cancer cells compared to GES-1. Overexpression of miR-129-5p inhibited EMT and proliferation. MiR-129-5p negatively and directly targeted HMGB1. HMGB1 was upregulated in gastric cancer cells and HMGB1 knocked-down inhibited EMT and cell proliferation.
Taken together, upregulation of miR-129-5p associated with gastric cancer proliferation and EMT, and serves as a potential diagnostic and therapeutic target via miR-129-5p/HMGB1 pathway in gastric cancer.</description><identifier>ISSN: 0344-0338</identifier><identifier>EISSN: 1618-0631</identifier><identifier>DOI: 10.1016/j.prp.2018.12.024</identifier><identifier>PMID: 30635217</identifier><language>eng</language><publisher>Germany: Elsevier GmbH</publisher><subject>Epithelial mesenchymal transition ; Gastric cancer ; HMGB1 ; miR-129-5p ; Proliferation</subject><ispartof>Pathology, research and practice, 2019-04, Vol.215 (4), p.676-682</ispartof><rights>2019</rights><rights>Copyright © 2019. Published by Elsevier GmbH.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c353t-8c70e90f33e001501ce0aee13b6b307f28b7628183a4aebbbd8152477fc55b743</citedby><cites>FETCH-LOGICAL-c353t-8c70e90f33e001501ce0aee13b6b307f28b7628183a4aebbbd8152477fc55b743</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.prp.2018.12.024$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,780,784,3550,27924,27925,45995</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/30635217$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Wang, Shaocheng</creatorcontrib><creatorcontrib>Chen, Yanyan</creatorcontrib><creatorcontrib>Yu, Xiongfei</creatorcontrib><creatorcontrib>Lu, Yimin</creatorcontrib><creatorcontrib>Wang, Haoao</creatorcontrib><creatorcontrib>Wu, Fusheng</creatorcontrib><creatorcontrib>Teng, Lisong</creatorcontrib><title>miR-129-5p attenuates cell proliferation and epithelial mesenchymal transition via HMGB1 in gastric cancer</title><title>Pathology, research and practice</title><addtitle>Pathol Res Pract</addtitle><description>The miR-129-5p has been reported to be aberrant expression and exert vital roles in tumor progression of various malignancies. However, the effects on EMT in gastric cancer and its precise molecular mechanism in gastric cancer remain unclear.
RT-qPCR was performed to evaluate the expression level of miR-129-5p and HMGB1 in cell lines. Cell proliferation was detected via CCK-8. The epithelial mesenchymal transition (EMT) related proteins and the expression of HMGB1 were detected by western blot analysis. Luciferase assays were used to validate binding seeds between miR-129-5p and HMGB1.
miR-129-5p was downregulated in gastric cancer cells compared with GES-1. At the same time EMT was promoted in gastric cancer cells compared to GES-1. Overexpression of miR-129-5p inhibited EMT and proliferation. MiR-129-5p negatively and directly targeted HMGB1. HMGB1 was upregulated in gastric cancer cells and HMGB1 knocked-down inhibited EMT and cell proliferation.
Taken together, upregulation of miR-129-5p associated with gastric cancer proliferation and EMT, and serves as a potential diagnostic and therapeutic target via miR-129-5p/HMGB1 pathway in gastric cancer.</description><subject>Epithelial mesenchymal transition</subject><subject>Gastric cancer</subject><subject>HMGB1</subject><subject>miR-129-5p</subject><subject>Proliferation</subject><issn>0344-0338</issn><issn>1618-0631</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2019</creationdate><recordtype>article</recordtype><recordid>eNp9kE1P3DAQhq2qqCy0P6CXysdeEmZsJ_GKE6AWkEBIiJ4tx5kUr_KF7UXi3-NloceePLKeeTXvw9h3hBIB65NNuYSlFIC6RFGCUJ_YCmvUBdQSP7MVSKUKkFIfsqMYNwDQgMIv7FBmoBLYrNhm9PcFinVRLdymRNPWJorc0TDwJcyD7ynY5OeJ26njtPj0SIO3Ax8p0uQeX8Y8p2Cn6N-oZ2_51e3lOXI_8b82puAdd3ZyFL6yg94Okb69v8fsz-9fDxdXxc3d5fXF2U3hZCVToV0DtIZeSgLACtARWCKUbd1KaHqh26YWGrW0ylLbtp3GSqim6V1VtY2Sx-znPjff_7SlmMzo466QnWjeRpN7r2WtVKUzinvUhTnGQL1Zgh9teDEIZqfYbPLPYnaKDQqTFeedH-_x23ak7t_Gh9MMnO4ByiWfPQUTnc-uqPOBXDLd7P8T_woy-ov2</recordid><startdate>20190401</startdate><enddate>20190401</enddate><creator>Wang, Shaocheng</creator><creator>Chen, Yanyan</creator><creator>Yu, Xiongfei</creator><creator>Lu, Yimin</creator><creator>Wang, Haoao</creator><creator>Wu, Fusheng</creator><creator>Teng, Lisong</creator><general>Elsevier GmbH</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20190401</creationdate><title>miR-129-5p attenuates cell proliferation and epithelial mesenchymal transition via HMGB1 in gastric cancer</title><author>Wang, Shaocheng ; Chen, Yanyan ; Yu, Xiongfei ; Lu, Yimin ; Wang, Haoao ; Wu, Fusheng ; Teng, Lisong</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c353t-8c70e90f33e001501ce0aee13b6b307f28b7628183a4aebbbd8152477fc55b743</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2019</creationdate><topic>Epithelial mesenchymal transition</topic><topic>Gastric cancer</topic><topic>HMGB1</topic><topic>miR-129-5p</topic><topic>Proliferation</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Wang, Shaocheng</creatorcontrib><creatorcontrib>Chen, Yanyan</creatorcontrib><creatorcontrib>Yu, Xiongfei</creatorcontrib><creatorcontrib>Lu, Yimin</creatorcontrib><creatorcontrib>Wang, Haoao</creatorcontrib><creatorcontrib>Wu, Fusheng</creatorcontrib><creatorcontrib>Teng, Lisong</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Pathology, research and practice</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Wang, Shaocheng</au><au>Chen, Yanyan</au><au>Yu, Xiongfei</au><au>Lu, Yimin</au><au>Wang, Haoao</au><au>Wu, Fusheng</au><au>Teng, Lisong</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>miR-129-5p attenuates cell proliferation and epithelial mesenchymal transition via HMGB1 in gastric cancer</atitle><jtitle>Pathology, research and practice</jtitle><addtitle>Pathol Res Pract</addtitle><date>2019-04-01</date><risdate>2019</risdate><volume>215</volume><issue>4</issue><spage>676</spage><epage>682</epage><pages>676-682</pages><issn>0344-0338</issn><eissn>1618-0631</eissn><abstract>The miR-129-5p has been reported to be aberrant expression and exert vital roles in tumor progression of various malignancies. However, the effects on EMT in gastric cancer and its precise molecular mechanism in gastric cancer remain unclear.
RT-qPCR was performed to evaluate the expression level of miR-129-5p and HMGB1 in cell lines. Cell proliferation was detected via CCK-8. The epithelial mesenchymal transition (EMT) related proteins and the expression of HMGB1 were detected by western blot analysis. Luciferase assays were used to validate binding seeds between miR-129-5p and HMGB1.
miR-129-5p was downregulated in gastric cancer cells compared with GES-1. At the same time EMT was promoted in gastric cancer cells compared to GES-1. Overexpression of miR-129-5p inhibited EMT and proliferation. MiR-129-5p negatively and directly targeted HMGB1. HMGB1 was upregulated in gastric cancer cells and HMGB1 knocked-down inhibited EMT and cell proliferation.
Taken together, upregulation of miR-129-5p associated with gastric cancer proliferation and EMT, and serves as a potential diagnostic and therapeutic target via miR-129-5p/HMGB1 pathway in gastric cancer.</abstract><cop>Germany</cop><pub>Elsevier GmbH</pub><pmid>30635217</pmid><doi>10.1016/j.prp.2018.12.024</doi><tpages>7</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0344-0338 |
| ispartof | Pathology, research and practice, 2019-04, Vol.215 (4), p.676-682 |
| issn | 0344-0338 1618-0631 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_2179364458 |
| source | Access via ScienceDirect (Elsevier) |
| subjects | Epithelial mesenchymal transition Gastric cancer HMGB1 miR-129-5p Proliferation |
| title | miR-129-5p attenuates cell proliferation and epithelial mesenchymal transition via HMGB1 in gastric cancer |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-24T18%3A26%3A39IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=miR-129-5p%20attenuates%20cell%20proliferation%20and%20epithelial%20mesenchymal%20transition%20via%20HMGB1%20in%20gastric%20cancer&rft.jtitle=Pathology,%20research%20and%20practice&rft.au=Wang,%20Shaocheng&rft.date=2019-04-01&rft.volume=215&rft.issue=4&rft.spage=676&rft.epage=682&rft.pages=676-682&rft.issn=0344-0338&rft.eissn=1618-0631&rft_id=info:doi/10.1016/j.prp.2018.12.024&rft_dat=%3Cproquest_cross%3E2179364458%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2179364458&rft_id=info:pmid/30635217&rft_els_id=S034403381831598X&rfr_iscdi=true |